Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is a narrative review synthesizing mechanistic and molecular knowledge about NK-DC interactions without presenting new experimental data, clinical trials, or empirical findings to evaluate.
A conceptual and critical synthesis of an emerging biological strategy without original experimental data, clinical trials, or validated clinical outcomes in the source population.
This is a narrative review synthesizing mechanistic concepts and early clinical observations rather than reporting original experimental or clinical trial data with defined endpoints and effect sizes.
A narrative review synthesizing biological rationale, mechanisms, and current clinical evidence for bispecific antibodies across gastrointestinal cancers, offering expert perspective on therapeutic potential and future directions rather than reporting a primary clinical trial result.
This is a mechanistic proof-of-concept study in a preclinical model demonstrating a novel nanovaccine strategy; it lacks human data, phase classification, or clinical endpoints needed for stronger evidence grading.
A narrative review synthesizing mechanistic concepts and therapeutic potential of lectin–glycan interactions in cancer immunity, raising questions rather than reporting empirical results or clinical outcomes.
This is a mechanistic review discussing potential strategies to restore MHC-I in CNS cancers, raising questions about therapeutic approaches rather than presenting experimental results or clinical evidence.
A narrative mechanism-based review synthesizing evidence across drug classes to guide clinical decision-making in cervical cancer treatment, without presenting original trial data or meta-analytic synthesis.